Edwards Lifesciences (EW)

R&D Expense Growth

5.92%

Quarterly · Period ending:

EW logo

EW R&D Expense Growth

Latest reported5.92%
EW Quarterly R&D Growth (QoQ) (0.00% → 5.92%)
High-resolution chart · PNG

EW r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
5.9248%
-1.6436%
-4.6313%
1.6293%
8.4839%
-6.0863%
6.985%
-7.0433%
6.194%
6.0306%
-0.2883%
-0.3693%
-6.6998%
12.4892%
-0.5993%
-6.8581%
9.7113%
-1.8041%
-2.1849%
5.6369%
8.8406%
5.7741%
0.1023%
7.3586%
-2.8282%
-3.3522%
-0.8184%
1.876%
11.9603%
5.0889%
0.8035%
4.9968%
7.6117%
-2.3192%
2.5892%
6.3244%
4.4289%
12.0104%
1.6814%
0.0886%
10.2539%
4.277%
-2.7723%
3.5897%
12.8472%
2.8571%
-4.1096%
-1.6835%
3.8462%
9.1603%
-6.5398%
4.472%
0.8772%
6.5421%
1.4905%
-0.2703%
7.8717%
13.0148%
-1.6207%
-4.9307%
10%
5.5456%
6.0721%
4.1502%
11.9469%
-6.4182%
8.0537%
4.9296%
6.7669%
11.4525%
1.9943%
-0.8475%
7.5988%
-1.791%
8.4142%
6.1856%
1.0417%
-4%
6.7616%
-2.7682%
7.037%
4.6512%
7.5%
-0.8264%
-3.2%
6.8376%
6.8493%
5.7971%
-1.4286%
10.5263%
13.0952%
-6.6667%
-5.2632%
7.3446%
14.1935%
-6.6265%
7.7922%
6.9444%
2.8571%
3.7037%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.